Investment Outlook For Cell And Gene Therapies Is Cautiously Optimistic
Cell And Gene Therapy Developers Raised $13.3bn In Financing In 2018
Executive Summary
Investors at Alliance for Regenerative Medicine’s Investor Day in March 2019 were bullish on cell and gene therapies, but some worry about the market overcrowding.